- Open
- 43.10
- High
- 43.10
- Low
- 43.10
- Close
- 43.10
- Change
- -3.10 (-7.19%)
- Volume
- 39,301
⌘K
| 21 Apr 2026 | 08:00:00 | Cancellation - Life Science REIT plc |
| 20 Apr 2026 | 15:25:01 | Form 8.3 - Life Science REIT plc |
| 20 Apr 2026 | 15:20:00 | Form 8.3 - Life Science REIT plc |
| 20 Apr 2026 | 15:05:24 | Form 8.5 (EPT/RI)-Replacement of Life Science REIT |
| 29 Apr 2025 | Annual Financial Report for the year ended 31 December 2024 | |
| 10 Apr 2024 | Annual Financial Report for the Year Ended 31 December 2023 | |
| 10 Jul 2023 | Annual Financial Report for the Year Ended 31 December 2022 |
The aim of Life Science investment is to offer investors a favorable level of overall return. The primary focus is on increasing capital growth while also providing a rising income stream by investing in a varied range of UK properties that are leased or planned to be leased to tenants in the life science industry.
| 21 Apr 2026 | 08:00:00 | Cancellation - Life Science REIT plc |
| 20 Apr 2026 | 15:25:01 | Form 8.3 - Life Science REIT plc |
| 20 Apr 2026 | 15:20:00 | Form 8.3 - Life Science REIT plc |
| 20 Apr 2026 | 15:05:24 | Form 8.5 (EPT/RI)-Replacement of Life Science REIT |
| 29 Apr 2025 | Annual Financial Report for the year ended 31 December 2024 | |
| 10 Apr 2024 | Annual Financial Report for the Year Ended 31 December 2023 | |
| 10 Jul 2023 | Annual Financial Report for the Year Ended 31 December 2022 |
The aim of Life Science investment is to offer investors a favorable level of overall return. The primary focus is on increasing capital growth while also providing a rising income stream by investing in a varied range of UK properties that are leased or planned to be leased to tenants in the life science industry.
| 20 Apr 2026 | 15:01:08 | Form 8.3 - LIFE SCIENCE REIT PLC |
| 20 Apr 2026 | 15:01:08 | Form 8.3 - LIFE SCIENCE REIT PLC |
